NLRP3 and Ataxia: Acrylamide exposure caused significant activation of NLRP3 inflammasomes and neuroinflammation, whereas inhibiting these effects through specific NLRP3 inflammasome blocker MCC950 intervention or NLRP3 knockout significantly ameliorated AA-induced ataxia, cerebellar Purkinje cell degeneration and apoptosis.